Abbott is introducing in Europe its XIENCE Sierra stent following receipt of the CE Mark of approval. The device is based on the popular XIENCE everolimus-eluting stent platform.
The new installment of the XIENCE features a narrower profile, greater flexibility, and available in longer lengths and smaller diameters, compared to previous device generations. It promises to be easier to deliver into and open particularly well blocked lesions while relying on much less pushing force from the physician to do so.
The improved flexibility is thanks to narrower strut crests and narrower, more pliable links. A thinner balloon makes the whole device narrower, resulting in a crossing profile of .039″, and more flexible as well.
Product page: XIENCE Sierra…
Via: Abbott…